Filing Flows › Bruker (BRKR) › R&D spending
Bruker (BRKR) R&D spending by quarter
Bruker's R&D spending was $92.0M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 7 quarters it ranged from $92.0M (Q3 2026) to $101M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $92.0M | -2% | -6% |
| Q2 2026 | $94.3M | -7% | -6% |
| Q1 2026 | $101M | +2% | +4% |
| Q4 2025 | $99.6M | +1% | — |
| Q3 2025 | $98.3M | -2% | — |
| Q2 2025 | $100M | +3% | — |
| Q1 2025 | $97.1M | — | — |
Q3 2026 at a glance
Bruker, Q3 2026: revenue $874M (+2% year over year), operating margin -10.4%, net loss $110M, operating cash flow $118M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bruker's R&D spending?
Bruker's R&D spending was $92.0M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Bruker's R&D spending changed?
Over the last 7 quarters it ranged from $92.0M (Q3 2026) to $101M (Q1 2026).